Skip to content
  • Home
  • Products
    • Extraction technology
    • Software solutions
  • Team members
  • Contact
Menu
  • Home
  • Products
    • Extraction technology
    • Software solutions
  • Team members
  • Contact
Home
Products
Extraction technology
Software solutions
Team members
Contact
Twitter
Read more about the article ALTOmate v.1.2.1 is released on schedule to improve selectivity in regions with poor alignment

ALTOmate v.1.2.1 is released on schedule to improve selectivity in regions with poor alignment

  • Post author:oncodia
  • Post published:December 30, 2021
  • Post category:Uncategorized

On 30th of December, 2021 Oncodia released a scheduled update of ALTOmate to version 1.2.1. The new version improves the selectivity of the mutation output in regions with poor alignment…

Continue ReadingALTOmate v.1.2.1 is released on schedule to improve selectivity in regions with poor alignment

Recent Posts

  • On 28th-29th of April, Oncodia will proudly present the company portfolio at the Nordic Precision Medicine Forum in Stockholm and at the same time participate in the 12th NACG workshop in Reykjavik, Iceland.
  • ALTOmate v.2 targets to cover ion semiconductor sequencing space
  • ALTOmate v.1.2.1 is released on schedule to improve selectivity in regions with poor alignment
  • Oncodia released a scheduled update of VARify to v.1.1.0
  • ALTOmate v.1.2.0 was released on schedule to increase mutation sensitivity and enhance the sequencing data preprocessing

Recent Comments

    Archives

    • April 2022
    • December 2021
    • October 2021
    • July 2021
    • May 2021
    • March 2021
    • February 2021
    • December 2020
    • August 2020
    • April 2020
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • May 2019

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.I agree